97 related articles for article (PubMed ID: 1337350)
1. The bactericidal activity of sparfloxacin.
Lewin CS; Morrissey I; Smith JT
J Antimicrob Chemother; 1992 Nov; 30(5):625-32. PubMed ID: 1337350
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal action of PD127,391, an enhanced spectrum quinolone.
Lewin CS; Amyes SG
J Med Microbiol; 1990 Sep; 33(1):67-70. PubMed ID: 2231674
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
Lewin CS
J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
Morrissey I; Smith JT
J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
[TBL] [Abstract][Full Text] [Related]
5. Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.
Ito T; Matsumoto M; Nishino T
Antimicrob Agents Chemother; 1995 Jul; 39(7):1522-5. PubMed ID: 7492097
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Smith KR; Cobbs CG
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
[TBL] [Abstract][Full Text] [Related]
7. Activity of sparfloxacin on Staphylococcus epidermidis attached to plastic catheters.
Pascual A; García I; Ramirez de Arellano E; Perea EJ
J Antimicrob Chemother; 1995 Aug; 36(2):425-30. PubMed ID: 8522473
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of quinolones against staphylococci and relationship with their in vitro bactericidal activity.
Ramón MS; Cantón E; Pemán J; Pastor A; Martínez JP
Chemotherapy; 1999; 45(3):175-82. PubMed ID: 10224339
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
10. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.
Lewin CS; Amyes SG; Smith JT
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):731-3. PubMed ID: 2506044
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of trovafloxacin (CP-99,219).
Morrissey I
J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species.
Takahata M; Yonezawa M; Matsubara N; Watanabe Y; Narita H; Matsunaga T; Igarashi H; Kawahara M; Onodera S; Oishi Y
J Antimicrob Chemother; 1997 Sep; 40(3):383-6. PubMed ID: 9338491
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal mechanism of gatifloxacin compared with other quinolones.
Gradelski E; Kolek B; Bonner D; Fung-Tomc J
J Antimicrob Chemother; 2002 Jan; 49(1):185-8. PubMed ID: 11751786
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
[TBL] [Abstract][Full Text] [Related]
17. In-vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin.
Pérez-Giraldo C; Rodríguez-Benito A; Morán FJ; Hurtado C; Blanco MT; Gómez-García AC
J Antimicrob Chemother; 1994 Apr; 33(4):845-8. PubMed ID: 8056703
[No Abstract] [Full Text] [Related]
18. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae.
Lemmen SW; Häfner H; Klik S; Lütticken R; Zolldann D
Chemotherapy; 2003 May; 49(1-2):33-5. PubMed ID: 12714807
[TBL] [Abstract][Full Text] [Related]
19. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
[TBL] [Abstract][Full Text] [Related]
20. Effect of phagocytosis of bacteria on the uptake of sparfloxacin by human neutrophils.
García I; Pascual A; Ballesta S; Perea EJ
Chemotherapy; 1996; 42(6):465-7. PubMed ID: 8957582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
